Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder

NCT03581643 is registered in ClinicalTrials.gov with Andreas Monsch as lead sponsor.

NCT NCT03581643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03581643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder
Lead sponsor
Andreas Monsch
Phase
Observational
Overall status
Completed
Start date
March 6, 2017
Completion date
May 8, 2018
Enrollment
430 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment